Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Farmaco ; 58(12): 1235-42, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14630233

ABSTRACT

The different dialkyl and diaryl diselenides with carbamoyl and sulfamoyl moieties 2, 3, 5 and other substituents in the ortho position of benzene ring 4, 7, 8 as well as derivatives of 1,2,4-benzoselenadiazine (6) were designed as antiviral and antimicrobial agents and synthesized. Some of them, particularly 8a and 8b, were found in the antiviral assay in vitro to be strong inhibitors of cytopathic activity encephalomyocarditis virus (EMCV). The compound 4a and 8a were found to have a broad spectrum of acivity against bacteria, yeasts and pathogenic fungi in vitro.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Antiviral Agents/chemical synthesis , Organoselenium Compounds/chemical synthesis , Animals , Anti-Bacterial Agents/pharmacology , Antiviral Agents/pharmacology , Cell Line, Tumor , Humans , Mice , Microbial Sensitivity Tests/methods , Organoselenium Compounds/pharmacology
2.
Arch Immunol Ther Exp (Warsz) ; 40(3-4): 229-34, 1992.
Article in English | MEDLINE | ID: mdl-1300988

ABSTRACT

Ebselen is known as anti-inflammatory and anti-oxidant selenium containing drug. We have synthetized 13 seleno-organic compounds, analogs of ebselen. Seven of them were found to be inducers of interferon gamma (IFN-gamma) and/or tumor necrosis factor alpha (TNF-alpha) in human peripheral blood leukocytes (PBL) cultures. The most active cytokine inducers were: 2-phenyl-1,2-benzisoselenazol-3(2H)-one (1, ebselen), bis [2-(N-phenylcarbamoyl)]phenyl diselenide (7) and bis (2-[N-(2-pyridyl)carbamoyl])phenyl diselenide (8). The amounts of IFN and TNF produced by PBL cultures in response to the seleno-organic compounds were found to be similar to that induced by phytohemagglutinin (PHA). The activities of the seleno-organic compounds were dose-dependent and related to the chemical structure of the drugs suggesting involvement of the specific cytokine-inducer receptor. The simultaneous inductions of IFN-gamma and TNF-alpha were highly correlated, but independent on each other.


Subject(s)
Interferon-gamma/biosynthesis , Organoselenium Compounds/pharmacology , Tumor Necrosis Factor-alpha/biosynthesis , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Azoles/pharmacology , Humans , In Vitro Techniques , Isoindoles , Leukocytes/drug effects , Leukocytes/immunology , Lipopolysaccharides/pharmacology , Molecular Structure , Organoselenium Compounds/chemistry , Phytohemagglutinins/pharmacology , Structure-Activity Relationship
3.
Experientia ; 46(3): 308-11, 1990 Mar 15.
Article in English | MEDLINE | ID: mdl-2107096

ABSTRACT

A number of organoselenium compounds have been described as anti-inflammatory, antioxidant, glutathione peroxidase-like agents and inhibitors of prostaglandin synthesis. Here we report that bis [2-(N-phenyl-carboxamido)]phenyl diselenide, 2-phenyl-1,2-benzisoselenazol-3(2H)-one (Ebselen) and related compounds are inducers of interferon gamma (IFN-gamma) and tumor necrosis factor (TNF) in human peripheral blood leukocytes. The IFN and TNF response was rapid, occurring within 20 h, and high--up to 1000 and 2000 units ml-1--and was clearly related to the dosage and the structure of the compounds. The action of the compounds and phytohemagglutinin was synergistic. The IFN gamma and TNF production was reduced after removing adherent cells. Although the mode of action of the compounds is not known, they appear to interact directly or indirectly with both adherent and non-adherent leukocytes, and stimulate the synthesis of a set of different cytokines including factors controlling the cell proliferation. Therefore, organoselenides may be regarded as the biological response modifiers.


Subject(s)
Adjuvants, Immunologic , Interferon Inducers , Interferon-gamma/biosynthesis , Leukocytes/drug effects , Organometallic Compounds/pharmacology , Organoselenium Compounds , Selenium/pharmacology , Tumor Necrosis Factor-alpha/biosynthesis , Antiviral Agents , Azoles/administration & dosage , Azoles/pharmacology , Cells, Cultured , Chemical Phenomena , Chemistry , Dose-Response Relationship, Drug , Drug Synergism , Humans , Immunologic Factors , Isoindoles , Leukocytes/metabolism , Organometallic Compounds/administration & dosage , Phytohemagglutinins/pharmacology , Selenium/administration & dosage , Stimulation, Chemical , Structure-Activity Relationship
4.
Arch Immunol Ther Exp (Warsz) ; 31(1): 99-106, 1983.
Article in English | MEDLINE | ID: mdl-6615170

ABSTRACT

Biological effects of conjugates of quinone derivatives with antibodies were studied. Two methods of conjugation of aziridine derivatives of quinone with anti-L-1210 antibodies were used: the direct substitution of the protein amino groups or thiolation of immunoglobulins and subsequent substitution of the sulfhydryl groups introduced. The reactions were carried out in 10% solutions of DMF at pH 8.3-8.9. The biological activity of conjugates, in vitro, was controlled using L-1210 and HeLa cells by measuring the inhibition of incorporation of labeled thymidine. The growth of L-1210 cells was more strongly inhibited by conjugates prepared with anti-L-1210 antibodies than by conjugates with nonimmune IgG. No difference in biological activity was found between conjugates prepared from anti-L-1210 antibodies and normal IgG in tests with HeLa cells.


Subject(s)
Antibodies, Neoplasm/immunology , Cytotoxicity, Immunologic , Leukemia L1210/immunology , Quinones/immunology , Adjuvants, Immunologic , Animals , HeLa Cells/immunology , Mice , Quinones/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...